News | April 28, 2026
Aurigene bets big on CRDMO expansion with $100 million outlay
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
Subscribe To Our Newsletter & Stay Updated
